We are live on ! Find out more
HF

HRT Financial Portfolio holdings

AUM $40.1B
1-Year Est. Return 58.22%
This Fund
S&P 500
This Quarter Est. Return
+7.21%
1 Year Est. Return
+58.22%
3 Year Est. Return
+133.11%
5 Year Est. Return
+158.39%
10 Year Est. Return
+582.81%
AUM
$8.2B
AUM Growth
+$1.12B
Cap. Flow
+$833M
Cap. Flow %
10.16%
Top 10 Hldgs %
26.95%
Holding
3,651
New
1,200
Increased
477
Reduced
532
Closed
1,218

Top Buys

Rank Stock Value
1
QQQ icon
Invesco QQQ Trust
QQQ
+$289M
2
IWM icon
iShares Russell 2000 ETF
IWM
+$179M
3
VLO icon
Valero Energy
VLO
+$138M
4
LIN icon
Linde
LIN
+$109M
5
LLY icon
Eli Lilly
LLY
+$108M

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$234M
2
MCK icon
McKesson
MCK
+$118M
3
SNPS icon
Synopsys
SNPS
+$112M
4
TSLA icon
Tesla
TSLA
+$81.8M
5
EFA icon
iShares MSCI EAFE ETF
EFA
+$76.2M

Sector Composition

Rank Sector Weight
1 Technology 11.84%
2 Industrials 10.46%
3 Healthcare 9.19%
4 Financials 8.96%
5 Consumer Discretionary 8.72%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AMBI.WS
2151
DELISTED
Ambipar Emergency Response Warrants
AMBI.WS
$33K ﹤0.01%
+106,117
New +$45.1K
LDI icon
2152
loanDepot
LDI
$516M
$32K ﹤0.01%
+20,390
New +$42.7K
AIIOW
2153
Robo.ai Inc Warrant
AIIOW
$436K
$32K ﹤0.01%
156,549
+50
+0% +$11
ADCT icon
2154
ADC Therapeutics
ADCT
$144M
$31K ﹤0.01%
+16,334
New +$60.3K
BKKT icon
2155
Bakkt Inc
BKKT
$337M
$31K ﹤0.01%
+726
New +$28.2K
YARW
2156
Yarrow Bioscience, Inc. Common Stock
YARW
$111M
$31K ﹤0.01%
+206
New +$37K
ESPR
2157
DELISTED
Esperion Therapeutics
ESPR
$30K ﹤0.01%
19,423
-433
-2% -$2.23K
PBLA
2158
DELISTED
Panbela Therapeutics, Inc. Common Stock
PBLA
$30K ﹤0.01%
+114
New +$110K
GNLN icon
2159
Greenlane Holdings
GNLN
$1.23M
0
SPRB
2160
Spruce Biosciences
SPRB
$129M
$29K ﹤0.01%
+178
New +$33.1K
RNWWW
2161
ReNew Energy Global PLC Warrant
RNWWW
$44.5K
$28K ﹤0.01%
33,292
ORKA
2162
Oruka Therapeutics
ORKA
$5.96B
$28K ﹤0.01%
+1,201
New +$31.6K
KOPN icon
2163
Kopin
KOPN
$791M
$27K ﹤0.01%
+24,856
New +$30.4K
ACB
2164
Aurora Cannabis
ACB
$185M
$26K ﹤0.01%
+3,760
New +$32.9K
EUDA icon
2165
EUDA Health Holdings
EUDA
$47.6M
$26K ﹤0.01%
+871
New +$29.5K
RIGL icon
2166
Rigel Pharmaceuticals
RIGL
$750M
$26K ﹤0.01%
2,043
-16,093
-89% -$256K
AFRIW icon
2167
Forafric Global PLC Warrants
AFRIW
$11.5M
$25K ﹤0.01%
38,393
RGS icon
2168
Regis Corp
RGS
$70.2M
$25K ﹤0.01%
+1,169
New +$32.3K
NMTR
2169
DELISTED
9 Meters Biopharma
NMTR
$25K ﹤0.01%
18,249
-24,281
-57% -$45.8K
NNAVW
2170
DELISTED
NextNav Inc Warrant
NNAVW
$24K ﹤0.01%
43,940
STXS icon
2171
Stereotaxis
STXS
$141M
$24K ﹤0.01%
+12,012
New +$27K
GNS icon
2172
Genius Group
GNS
$30.4M
$23K ﹤0.01%
+1,743
New +$59.4K
SKYH.WS icon
2173
Sky Harbour Group Warrants
SKYH.WS
$21.4M
$23K ﹤0.01%
47,756
YSG
2174
Yatsen Holding
YSG
$319M
$23K ﹤0.01%
+3,191
New +$24K
ALGS icon
2175
Aligos Therapeutics
ALGS
$34.9M
$22K ﹤0.01%
1,051
-1,599
-60% -$61.1K

Similar funds

HRT Financial's Q1 2023 Portfolio in Review

As of Q1 2023, HRT Financial held 3,651 positions worth $8.2B, up 16% from $7.07B the previous quarter. Its ten largest holdings account for 27% of the portfolio.

HRT Financial deployed $833M of net new capital in Q1 2023, opening 1,200 new positions and adding to 477 existing holdings. Its largest new stake was Valero Energy: 1,028,681 shares worth $144M.

By sector, the portfolio is most concentrated in Technology at 12% of assets, down from 18% a quarter earlier, followed by Industrials and Healthcare.

On the sell side, the largest reduction was McKesson, an estimated $118M trimmed.

  • HRT Financial's largest Q1 2023 buy was Valero Energy: 1,028,681 shares worth $144M.
  • HRT Financial added most to Invesco QQQ Trust in Q1 2023, an estimated $289M increase.
  • HRT Financial's biggest Q1 2023 reduction was McKesson, cutting an estimated $118M.
  • HRT Financial fully exited Apple in Q1 2023, selling an estimated $234M.
  • HRT Financial's ten largest holdings make up 27% of its $8.2B portfolio in Q1 2023.
  • HRT Financial opened 1,200 new positions and closed 1,218 in Q1 2023.
  • HRT Financial's portfolio value rose 16% quarter-over-quarter to $8.2B.

Based on HRT Financial's 13F filing for Q1 2023, filed 12 May 2023.